Treatment of moderate rheumatoid arthritis

Saved in:
Bibliographic Details
Published in:Rheumatology (Oxford, England) England), 2022-02, Vol.61 (2), p.478-479
Main Author: McKenna, Frank
Format: Article
Language:English
Subjects:
Antirheumatic Agents - therapeutic use
Arthritis, Rheumatoid - drug therapy
Guideline Adherence
Health Services Accessibility
Humans
Severity of Illness Index
Tumor Necrosis Factor Inhibitors - therapeutic use
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c393t-99e1fcd170528d99f55baab6dbcd27ae5630e9b32090f25f3a3b0f85208e07993
cites cdi_FETCH-LOGICAL-c393t-99e1fcd170528d99f55baab6dbcd27ae5630e9b32090f25f3a3b0f85208e07993
container_end_page 479
container_issue 2
container_start_page 478
container_title Rheumatology (Oxford, England)
container_volume 61
creator McKenna, Frank
description
doi_str_mv 10.1093/rheumatology/keab582
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2554354675</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1093/rheumatology/keab582</oup_id><sourcerecordid>2554354675</sourcerecordid><originalsourceid>FETCH-LOGICAL-c393t-99e1fcd170528d99f55baab6dbcd27ae5630e9b32090f25f3a3b0f85208e07993</originalsourceid><addsrcrecordid>eNqNkMtOwzAQRS0EoqXwBwhliZBCx3acxEtU8ZIqsSlry47HNJDUxXYW_XuK-hBLVnMX596RDiHXFO4pSD4NSxx6nXznPzbTL9RG1OyEjGlRshw4Z6fHzIoRuYjxEwAE5fU5GfGC1RIYH5O7RUCdelylzLus9xaDTpgdxlub6ZCWoU1tvCRnTncRr_Z3Qt6fHhezl3z-9vw6e5jnDZc85VIidY2lFQhWWymdEEZrU1rTWFZpFCUHlIYzkOCYcFxzA64WDGqESko-Ibe73XXw3wPGpPo2Nth1eoV-iIoJUXBRlJXYosUObYKPMaBT69D2OmwUBfVrSf21pPaWtrWb_YfB9GiPpYOWLTDdAX5Y_2_yBxlReKI</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2554354675</pqid></control><display><type>article</type><title>Treatment of moderate rheumatoid arthritis</title><source>Oxford Journals Online</source><source>Alma/SFX Local Collection</source><creator>McKenna, Frank</creator><creatorcontrib>McKenna, Frank</creatorcontrib><identifier>ISSN: 1462-0324</identifier><identifier>EISSN: 1462-0332</identifier><identifier>DOI: 10.1093/rheumatology/keab582</identifier><identifier>PMID: 34289023</identifier><language>eng</language><publisher>England: Oxford University Press</publisher><subject>Antirheumatic Agents - therapeutic use ; Arthritis, Rheumatoid - drug therapy ; Guideline Adherence ; Health Services Accessibility ; Humans ; Severity of Illness Index ; Tumor Necrosis Factor Inhibitors - therapeutic use</subject><ispartof>Rheumatology (Oxford, England), 2022-02, Vol.61 (2), p.478-479</ispartof><rights>The Author(s) 2021. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For permissions, please email: journals.permissions@oup.com 2021</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c393t-99e1fcd170528d99f55baab6dbcd27ae5630e9b32090f25f3a3b0f85208e07993</citedby><cites>FETCH-LOGICAL-c393t-99e1fcd170528d99f55baab6dbcd27ae5630e9b32090f25f3a3b0f85208e07993</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34289023$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>McKenna, Frank</creatorcontrib><title>Treatment of moderate rheumatoid arthritis</title><title>Rheumatology (Oxford, England)</title><addtitle>Rheumatology (Oxford)</addtitle><subject>Antirheumatic Agents - therapeutic use</subject><subject>Arthritis, Rheumatoid - drug therapy</subject><subject>Guideline Adherence</subject><subject>Health Services Accessibility</subject><subject>Humans</subject><subject>Severity of Illness Index</subject><subject>Tumor Necrosis Factor Inhibitors - therapeutic use</subject><issn>1462-0324</issn><issn>1462-0332</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNqNkMtOwzAQRS0EoqXwBwhliZBCx3acxEtU8ZIqsSlry47HNJDUxXYW_XuK-hBLVnMX596RDiHXFO4pSD4NSxx6nXznPzbTL9RG1OyEjGlRshw4Z6fHzIoRuYjxEwAE5fU5GfGC1RIYH5O7RUCdelylzLus9xaDTpgdxlub6ZCWoU1tvCRnTncRr_Z3Qt6fHhezl3z-9vw6e5jnDZc85VIidY2lFQhWWymdEEZrU1rTWFZpFCUHlIYzkOCYcFxzA64WDGqESko-Ibe73XXw3wPGpPo2Nth1eoV-iIoJUXBRlJXYosUObYKPMaBT69D2OmwUBfVrSf21pPaWtrWb_YfB9GiPpYOWLTDdAX5Y_2_yBxlReKI</recordid><startdate>20220202</startdate><enddate>20220202</enddate><creator>McKenna, Frank</creator><general>Oxford University Press</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20220202</creationdate><title>Treatment of moderate rheumatoid arthritis</title><author>McKenna, Frank</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c393t-99e1fcd170528d99f55baab6dbcd27ae5630e9b32090f25f3a3b0f85208e07993</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Antirheumatic Agents - therapeutic use</topic><topic>Arthritis, Rheumatoid - drug therapy</topic><topic>Guideline Adherence</topic><topic>Health Services Accessibility</topic><topic>Humans</topic><topic>Severity of Illness Index</topic><topic>Tumor Necrosis Factor Inhibitors - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>McKenna, Frank</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Rheumatology (Oxford, England)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>McKenna, Frank</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Treatment of moderate rheumatoid arthritis</atitle><jtitle>Rheumatology (Oxford, England)</jtitle><addtitle>Rheumatology (Oxford)</addtitle><date>2022-02-02</date><risdate>2022</risdate><volume>61</volume><issue>2</issue><spage>478</spage><epage>479</epage><pages>478-479</pages><issn>1462-0324</issn><eissn>1462-0332</eissn><cop>England</cop><pub>Oxford University Press</pub><pmid>34289023</pmid><doi>10.1093/rheumatology/keab582</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1462-0324
ispartof Rheumatology (Oxford, England), 2022-02, Vol.61 (2), p.478-479
issn 1462-0324
1462-0332
language eng
recordid cdi_proquest_miscellaneous_2554354675
source Oxford Journals Online; Alma/SFX Local Collection
subjects Antirheumatic Agents - therapeutic use
Arthritis, Rheumatoid - drug therapy
Guideline Adherence
Health Services Accessibility
Humans
Severity of Illness Index
Tumor Necrosis Factor Inhibitors - therapeutic use
title Treatment of moderate rheumatoid arthritis
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T17%3A20%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Treatment%20of%20moderate%20rheumatoid%20arthritis&rft.jtitle=Rheumatology%20(Oxford,%20England)&rft.au=McKenna,%20Frank&rft.date=2022-02-02&rft.volume=61&rft.issue=2&rft.spage=478&rft.epage=479&rft.pages=478-479&rft.issn=1462-0324&rft.eissn=1462-0332&rft_id=info:doi/10.1093/rheumatology/keab582&rft_dat=%3Cproquest_cross%3E2554354675%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c393t-99e1fcd170528d99f55baab6dbcd27ae5630e9b32090f25f3a3b0f85208e07993%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2554354675&rft_id=info:pmid/34289023&rft_oup_id=10.1093/rheumatology/keab582&rfr_iscdi=true